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Summary
Background:  The  purpose  of  this  study  was  to  identify  clinical  characteristics  of  preterm  delivery
at less  than  37  weeks  of  gestation  (PD37G)  and  prenatal  events  associated  with  preterm  delivery
at less  than  35  weeks  of  gestation  (PD35G)  in  women  with  cardiac  disease  (WCD).
Methods:  A  case—control  study  was  conducted  of  599  pregnancies  in  479  single  pregnant  women
with congenital  or  acquired  cardiac  lesions  or  cardiac  arrhythmias.  The  relevant  variables
were compared  between  women  who  had  PD35G  (n  =  37)  and  the  controls  (n  =  562).  Cardiac
dysfunction  was  deﬁned  as  the  appearance  of  clinical  symptoms  of  heart  failure,  abnormal
electrocardiogram,  or  cardiac  ultrasonography.
Results:  PD37G  occurred  in  77  cases  (12.9%).  The  spontaneous  and  indicated  preterm  delivery
was 26  (33.8%)  and  51  (66.2%)  cases,  respectively.  The  presence  of  cardiac  dysfunction  [odds
ratio (OR)  21.82,  95%  conﬁdence  interval  (CI)  8.3—57.49],  New  York  Heart  Association  class  II
(OR 3.96,  95%  CI  1.05—14.93),  cardiomyopathy  (OR  7.74,  95%  CI  1.69—35.45)  and  pregnancy-
induced hypertension  (PIH)  (OR  3.15,  95%  CI  1.37—7.24)  was  signiﬁcantly  associated  with  an
increased risk  of  PD35G.  No  maternal  death  was  seen  within  one  year  after  delivery.
Conclusions:  Although  pregnancy  and  delivery  are  generally  safe  in  WCD,  it  is  necessary  to  be
aware of  the  risk  factors  of  cardiac  dysfunction,  cardiomyopathy,  and  PIH  from  the  aspect  of
PD35G.
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ntroduction
ith  recent  advances  in  medical  and  surgical  therapy,  there
as  been  a  rapid  increase  in  the  number  of  women  with
eart  disease,  reaching  childbearing  age.  Accordingly,  preg-
ancy  in  these  women  poses  a  new  important  clinical  issue.
everal  investigations  have  presented  the  safety  and  risks
nvolved  in  such  pregnancy  [1—11]. Since  the  number  of
omen  in  each  report  is  not  large  enough  and  few  stud-
es  have  conducted  multivariate  analyses  [1,2,4], we  should
ncrease  our  experience  and  knowledge  to  clarify  clinical
roblems  related  to  pregnancy  in  these  women  in  order
o  deﬁne  indications  for  pregnancy  itself  and  their  obstet-
ic  management.  It  is  also  very  important  to  clarify  how
he  cardiovascular  condition  of  mothers  affects  pregnancy,
elivery,  and  fetuses  [12,13].
Prematurity  is  a  particularly  signiﬁcant  risk  factor  for  sur-
ival  and  is  associated  with  increased  perinatal  mortality.
eports  comparing  data  in  pregnant  women  with  heart  dis-
ase  and  with  control  data  indicate  a  signiﬁcantly  increased
ate  of  preterm  delivery  [3,7]. In  general,  preterm  delivery
s  divided  into  two  categories:  spontaneous  and  indicated
reterm  delivery  [14]. Preterm  delivery  in  patients  with
eart  disease  is  most  often  indicated,  because  it  is  primar-
ly  related  to  an  increased  incidence  of  cardiac  dysfunction
3];  however,  the  precise  factors  predisposing  to  preterm
elivery  remain  unclear.
The  purpose  of  this  study,  therefore,  was  to  review  our
ata  to  demonstrate  factors  inﬂuencing  the  outcome  of
regnancy  and  the  fetus  of  mothers  with  heart  disease,  and
o  identify  prenatal  events  associated  with  preterm  deliv-
ry  at  less  than  35  weeks  of  gestation  in  women  with  heart
isease.
ethods
rganization  and  subjects
his  study  was  conducted  after  obtaining  approval  from
he  Institutional  Review  Board.  A  case—control  study  was
onducted  of  599  pregnancies  from  479  single  pregnant
omen  with  congenital  or  acquired  cardiac  lesions  or  car-
iac  arrhythmia  in  all  singleton  births  between  22  and  41
eeks  of  gestation  at  the  Maternal  and  Perinatal  Centre,
okyo  Women’s  Medical  University  Hospital  between  January
,  1991  and  December  31,  2005.  The  cardiac  lesion  was
ongenital  in  295  pregnancies,  acquired  in  84  pregnancies,
rrhythmia  in  186  pregnancies,  cardiomyopathy  in  18  preg-
ancies,  and  others  in  16  pregnancies.  The  cardiac  lesions
n  599  pregnancies  are  shown  in  Table  1.
eﬁnitions
he  gestational  age  was  determined  based  on  the  last
enstrual  period  and  standard  obstetric  ultrasonography.
ll  patients  were  permitted  to  continue  the  pregnancy  by
ardiologists  and  were  managed  in  collaboration  with  car-
iologists.  Multiple  pregnancies  were  excluded  from  this
tudy.
e
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Clinical  assessment  was  serially  undertaken  as  follows:
rior  to  the  pregnancy,  ﬁrst  check-up  during  pregnancy  at
—10  weeks’  gestation,  and  thereafter,  at  regular  intervals
ntil  delivery,  e.g.  each  subject  received  clinical  assessment
nce  in  1st  trimester,  once  in  2nd  trimester,  and  once  in
rd  trimester.  Details  of  the  mean  arterial  pressure,  use  of
ntihypertensive  medication,  and  complications  were  doc-
mented  at  each  visit.
Cardiac  dysfunction  was  diagnosed  by  the  cardiolo-
ists  during  pregnancy.  These  deﬁnitions  are  as  follows:
he  appearance  of  clinical  symptoms  of  heart  failure,
nd  newly  developed  abnormal  changes  on  electrocardio-
ram  and/or  on  echocardiography  [1,12]. Clinical  heart
ailure  was  deﬁned  as  any  of  these:  (1)  edema  in  face
r  extremities  resulting  in  irrational  gaining  of  body
eight,  shortness  of  breath  on  exertion  and/or  even  at
est,  and  signiﬁcantly  inadequate  sinus  tachycardia  differ-
nt  from  natural  increase  of  heart  rate  with  gestation;
2)  cardiomegaly  and/or  pulmonary  edema  on  chest  X-
ay  compared  to  original  appearances  in  pre-pregnancy.
bnormalities  on  electrocardiogram  had  been  originally
een  in  pre-pregnancy  for  those  pregnant  women  with
eart  disease  including  cardiomyopathy;  therefore,  the
eﬁnition  of  abnormal  electrocardiogram  was  newly  docu-
ented  tachyarrhythmia  such  as  non-sustained  ventricular
achycardia,  paroxysmal  supraventricular  tachycardia,  and
trial  ﬁbrillation,  bradyarrhythmia-like  sick  sinus  syndrome,
nd  signiﬁcant  increase  of  premature  ventricular/atrial
ontractions.  Cardiac  dysfunction  by  cardiac  ultrasonog-
aphy  was  deﬁned  as  any  of  the  following:  mitral  valve
rea  of  <1.5  cm2,  left  ventricular  outlet  tract  peak  gra-
ient  of  >30  mmHg,  right  ventricular  outlet  tract  peak
radient  of  >25  mmHg,  systemic  ventricular  ejection  frac-
ion  of  <40%,  left  ventricular  end  diastolic  dimension  of
4.8  cm,  and  left  ventricular  posterior  wall  thickness  of
13  mm  in  the  patient  with  hypertrophic  cardiomyopathy
1,15,16].
Preterm  labor  (PTL)  was  deﬁned  as  the  demonstrated
rogressive  dilation  of  the  cervix  with  uterine  contrac-
ions  before  36  weeks  of  gestation  [17]. Premature  rupture
f  membranes  (PROM)  was  deﬁned  as  the  leakage  of
atery  discharge  [18]. According  to  the  criteria  of  the
ational  High  Blood  Pressure  Education  Program  [19],
ypertensive  disorders  in  pregnancy  can  be  classiﬁed  as
ollows:  chronic  hypertension,  pregnancy-induced  hyperten-
ion  (PIH),  preeclampsia,  and  superimposed  preeclampsia.
he  diagnosis  of  PIH  was  made  in  women  whose  blood  pres-
ure  reached  140/90  mmHg  or  greater  for  the  ﬁrst  time
fter  pregnancy,  but  in  whom  proteinuria  was  not  identiﬁed
14,20].  Proteinuria  was  deﬁned  as  24-h  urinary  protein  of
0.3  g  or  persistent  protein  levels  of  30  mg/dL  (1  +  dipstick)
n  random  urine  samples.  Severe  proteinuria  was  deﬁned  as
4-h  urinary  protein  of  ≥2.0  g  persistent  2  +  protein  dipstick
eading  in  random  urine  samples  [14,20].
Patients  were  hospitalized  for  the  following:  hyperten-
ion,  PIH,  manifestation  of  cardiac  dysfunction,  severe
roteinuria,  PTL/PROM,  or  intrauterine  growth  restriction.
Fetal  assessment  consisted  of  initial  ultrasonography  tostimate  fetal  weight  and  amniotic  ﬂuid  volume,  followed
y  ultrasound  evaluation  every  7  days  for  fetal  growth.  Daily
on-stress  testing  was  performed,  and  a  biophysical  proﬁle
as  obtained  when  needed.
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Table  1  Nature  of  cardiac  lesion.
Cardiac  lesions  Pregnancies
(n)
Post-operative
subjects  (n)
Cardiac  medications  (n)
Diuretic  Anti-hypertensive
drugs
Digoxin  Warfarin
Congenital  heart  disease
Ventricular  septal  defect  140  57
Tetralogy  of  Fallot  54  53  8  3  4
Atrial septal  defect  49  29
Ebstein’s  anomaly  13  4
Congenitally  corrected
transposition  of  the
great  arteries
11 8 1 2
Single  ventricule
physiology
8  5
Patent  ductus  arteriosus 7 5
Atrioventricular  septal
defect
6 6
Complete  transposition  of
the  great  arteries
3 3 2
Others 4 3 1
Acquired  heart  disease
Mitral  regurgitation
and/or  mitral  valve
prolapse
49  8  3  1  4  5
Aortic regurgitation  16  7  2  1
Aortic stenosis  9  0
Pulmonary  stenosis  6  2
Mitral  stenosis  2  0
Others  2  0
Arrhythmia
Ventricular  premature
conductiona
71  0
Atrioventricular  block
1st  degree  6  0
2nd degree  7  0
3rd degree  16  0
Wolff—Parkinson—White
syndrome
19 0  1
Paroxysmal
supraventricular
tachycardia
17 0
Long O-T  syndrome  15  0
Premature  atrial
contractionb
11  0
Sick sinus  syndrome  8  0
Ventricular  tachycardia  8  0
Others  8  0  1
Cardiomyopathy
Hypertrophic
cardiomyopathy
14 0  4  1
Dilated cardiomyopathy  3  0  1
Idiopathic
cardiomyopathy
1 0
Others
Aortitis  syndrome  8  0
Marfan’s  syndrome  3  0
Coronary  artery  disease  5  0
a >10% of premature conduction among all QRS.
b >10% of premature atrial contraction of total beat.
2 Y.  Makino  et  al.
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Table  2  Clinical  characteristics  of  pregnant  women  with
cardiac disease.
Group  Total  (n  =  599)
Mean  maternal  age  (years)  30  ±  4.3
Primipara  (n)  214  (35.7%)
New  York  Heart  Association  functional  class  (n)
Class  I  577  (96.3%)
Class  II  22  (3.7%)
Cardiac medications
Diuretic  19  (3.2%)
Anti-hypertensive  drugs 7  (1.2%)
Digoxin 13  (2.2%)
Warfarin 6  (1.0%)
Cardiac  dysfunction  (n)  36  (6.0%)
cardiac ultrasonography  16  (44.4%)
clinical  symptoms  of  heart  failure  13  (36.1%)
abnormal  electrocardiogram  7  (19.4%)
Obstetrical  complications  (n)
Threatened  premature  labor  66  (11.0%)
Pregnancy-induced  hypertension  39  (6.5%)
Premature  rupture  of  membranes  8  (1.3%)
Gestational  week  on  admission  36.7  ±  4.2
Gestational  week  at  delivery
<37  weeks  (n)  77  (12.9%)
<35 weeks  (n)  37  (6.2%)
Method  of  delivery  (n)
Spontaneous  vaginal  delivery  (n)  269  (44.9%)
Operative  vaginal  delivery  109  (22.7%)
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Ritodrine  hydrochloride  was  administered  when  signs  of
TL  appeared  [17]. Magnesium  sulfate  administration  was
nitiated  in  preeclampsia  cases  for  hypertension  (blood  pres-
ure  140/90  mmHg  or  greater)  plus  overt  proteinuria  or  both
14,19].  The  administration  method  was  based  on  that  of
uspan  and  Ward,  with  the  intravenous  injection  of  MgSO4
 g  over  30  min  followed  by  1—2  g/h  with  close  monitoring  of
erum  magnesium  concentrations  [21].
Delivery  was  allowed  to  occur  with  the  onset  of  active
abor,  maternal  indications  such  as  manifestation  of  sig-
iﬁcant  cardiac  dysfunction,  onset  of  PIH,  intractable
ypertension,  fetal  indications  such  as  growth  arrest  of
he  fetus,  non-reassuring  fetal  status,  and  gestational  age
ore  than  37  weeks.  Cesarean  sections  were  carried  out  for
atients  who  had  previously  undergone  Cesarean  section,  as
ell  as  for  those  with  dystocia,  non-reassuring  fetal  status,
etal  malpresentation,  or  maternal  indications.
The  obstetric  notes  of  the  mothers  were  reviewed  by
 researcher  unaware  of  the  children’s  outcome.  Nearly
5  variables  were  assessed,  including  demographic  data,
regestational  factors,  and  prenatal  events.  The  preges-
ational  factors  were  age,  smoking  habit,  prenatal  care,
nd  maternal  medical  history  (complications,  family  his-
ory,  previous  obstetric  history,  and  history  of  the  relevant
urrent  pregnancy).  The  prenatal  events  were  cardiac  dys-
unction  and  obstetric  complications  such  as  PTL/PROM  and
IH.  Details  of  the  diagnosis,  onset,  duration,  and  clinical
anagement  of  any  relevant  condition  were  also  recorded.
Preterm  delivery  was  divided  into  two  groups:  sponta-
eous  (PTL  or  PROM)  and  indicated  (for  maternal  or  fetal
easons)  [22]. In  the  indicated  preterm  delivery  group,  the
iming  of  delivery  was  decided  by  case-by-case  beneﬁt/risk
ssessment.  Other  obstetric  events  included  PIH.  Maternal
eath  was  deﬁned  as  death  within  1-year  after  birth  accord-
ng  to  the  International  Classiﬁcation  of  Disease  (ICD)-10
23].
Short-term  neonatal  prognosis  was  deﬁned  as  any  of
he  following:  premature  birth  (<37  weeks  of  gestation),
mall-for-gestational  age  birth  weight  (<10th  percentile),
espiratory  distress  syndrome,  intraventricular  hemorrhage,
etal  death  (≥22  weeks  of  gestation),  neonatal  death  (within
8  days  after  birth),  or  infantile  death  at  discharge.  Long-
erm  neonatal  prognosis  was  deﬁned  as  cerebral  palsy  (CP),
orderline  (BL,  intelligence  quotient  or  development  quo-
ient:  70—84),  and  mental  retardation  (MR,  intelligence
uotient  or  development  quotient:  <70)  [24]. Poor  outcome
as  categorized  as  follows:  intrauterine  fetal  death,  neona-
al  death,  infantile  death,  and  neurological  handicap  (CP,
L,  and  MR).
tatistical  analysis
he  results  are  expressed  as  the  mean  ±  SD.  Each  pregnancy
as  treated  as  a  separate  data  unit.  Statistical  analysis  was
arried  out  using  the  2 test  and  Fisher’s  exact  probabil-
ty  test.  p-Values  <0.05  were  considered  signiﬁcant.  Odds
atios  (OR)  with  95%  conﬁdence  intervals  (CI)  were  calcu-
ated  to  estimate  the  relative  risk  between  case  and  control
ubjects  with  regard  to  the  risk  factors  for  preterm  birth  at
ess  than  35  weeks’  gestation.  Because  some  women  under-
ent  ≥1  pregnancy,  the  validity  of  treating  each  pregnancy
s
i
d
iCesarean  section 194  (32.4%)
s  an  independent  event  was  conﬁrmed  by  general  esti-
ating  equation  analysis  [25]. Results  were  compared  by
oth  univariate  and  multivariate  analyses.  Logistic  regres-
ion  models  were  used  to  assess  the  inﬂuence  of  confounding
actors.
esults
aternal  clinical  background  and  clinical  course
able  2  shows  the  maternal  characteristics.  The  baseline
ew  York  Heart  Association  (NYHA)  class  was  I  (n  =  577)  or
I  (n  =  22),  respectively.  Three  women  were  strongly  sus-
ected  of  having  bacterial  endocarditis  because  of  high
ever  and  documentation  of  the  bacteria  by  blood  cul-
ure,  which  was  successfully  treated  by  antibiotics.  Cardiac
ysfunction  occurred  in  36  cases  (6%)  (Table  2).  Of  the
6  patients,  signiﬁcant  deterioration  of  cardiac  function
etected  by  echocardiography  was  seen  in  16  (44%)  with
linical  or  subclinical  heart  failure.  Thirteen  developed  clin-
cal  symptoms  of  heart  failure  during  pregnancy  (36%).
here  were  7  patients  who  showed  additional  unfavor-
ble  abnormalities  on  electrocardiogram  with  gestation,
uch  as  non-sustained  ventricular  tachycardia,  paroxysmal
upraventricular  tachycardia,  atrial  ﬁbrillation,  signiﬁcant
ncrease  of  premature  ventricular/atrial  contractions,  and
eterioration  of  bradycardia  despite  expectation  of  natural
ncrease  of  heart  rate  during  pregnancy.  Six  women  required
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Table  3  Risk  factors  of  premature  birth  at  less  than  35  weeks  of  gestation  in  univariate  and  multivariate  analyses.
Case  (N  =  37)  Control  (N  =  562)  OR  (95%  CI)
(uinivariate  analysis)
OR  (95%  CI)
(multivariate  analysis)
N  (%)  N  (%)
Cardiac  dysfunction  18  48.6  18  8.9  27.15  (12.31—59.89)  21.82  (8.28—57.49)
Cardiomyopathy  9  24.3  9  4.4  30.00  (8.76—102.74)  7.74  (1.69—35.45)
New York  Heart  Association  class  II  7  18.9  15  2.7  10.42  (4.06—26.76)  3.96  (1.05—14.93)
Pregnancy induced  hypertension  7  18.9  32  5.7  3.86  (1.58—9.48)  3.15  (1.37—7.24)
Pulmonary hypertension  2  5.4  3  1.5  10.34  (1.67—63.85)  0.36  (0.02—8.49)
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dOR, odds ratio; CI, conﬁdence interval.
diuretics  and/or  intravenous  catecholamine  for  overt  con-
gestive  heart  failure  immediately  after  delivery.  Six  women
required  diuretics  and/or  intravenous  catecholamine  for
overt  congestive  heart  failure  immediately  after  deliv-
ery.  Two  women  also  had  complications  with  paroxysmal
supraventricular  tachycardia  and  one  had  incomplete  right
bundle  branch  block.
Sixty-six  patients  (11.0%)  suffered  from  PTL.  Thirty-nine
patients  (6.5%)  suffered  from  PIH.  Eight  patients  (1.3%)
suffered  from  preeclampsia.  Eight  patients  (1.3%)  suffered
from  PROM.
Cesarean  section  in  the  study  was  performed  in  194
patients  (32.4%).  Three  cardiac  operations  were  performed
after  delivery.  A  patient  with  Marfan’s  syndrome  underwent
David’s  operation.  A  patient  with  Tetralogy  of  Fallot  (TOF)
underwent  Bentall’s  operation.  A  patient  complicated  with
repaired  ventricular  septal  defect  and  unrepaired  Aortic
regurgitation  (AR)  had  AR  repaired.  No  maternal  death  was
seen  within  one  year  after  delivery.
Preterm  delivery  at  less  than  37  weeks’  gestation
Preterm  delivery  at  less  than  37  weeks’  gestation  occurred
in  77  cases  (12.9%)  (Table  2).  The  spontaneous  and  indi-
cated  preterm  delivery  was  26  (33.8%)  and  51  (66.2%)  cases,
respectively.  The  ratio  of  spontaneous  to  indicated  preterm
delivery  was  approximately  0.5.
The  rate  of  preterm  delivery  in  each  heart  disease
was  as  follows:  congenital  11.8%,  acquired  valvular  15.4%,
arrhythmias  8.6%,  cardiomyopathy  61.1%,  and  others  12.5%,
respectively  and  cardiomyopathy  was  signiﬁcantly  higher
than  for  other  heart  diseases  (p  <  0.05).
Risk  factors  for  preterm  delivery  at  less  than  35
weeks’ gestation
Preterm  delivery  at  less  than  35  weeks  of  gestation  occurred
in  38  cases  (6.3%).  Among  the  factors  regarded  as  possi-
ble  indicators  of  risk,  further  analysis  was  performed  using
logistic  regression  analysis.  Five  of  eleven  variables  found
by  univariate  analysis  to  be  signiﬁcant  factors  related  to
preterm  delivery  at  less  than  35  weeks  of  gestation  (Table  3).
From  logistic  analysis,  factors  associated  with  an  increased
risk  of  preterm  delivery  at  less  than  35  weeks  of  gestation
were  the  presence  of  cardiac  dysfunction  (OR  21.82,  95%  CI
8.28—57.49),  NYHA  class  II  (OR  3.96,  95%  CI  1.05—14.93),
w
i
m
aardiomyopathy  (OR  7.74,  95%  CI  1.69—35.45),  and  PIH  (OR
.15,  95%  CI  1.37—7.24)  and  were  signiﬁcantly  associated
ith  an  increased  risk  of  preterm  delivery  at  less  than
5  weeks  of  gestation.
erinatal  outcome
able  4  shows  the  perinatal  outcome.  The  mean  gesta-
ional  age  at  delivery  was  38.2  ±  2.4  (range:  23—42)  weeks
n  women  with  heart  disease.  The  mean  birth  weight  was
824.7  ±  546.4  g  (range  470—4465  g).  In  121  cases  (20.2%),
he  birth  weight  at  delivery  was  less  than  2500  g,  and  the
umber  of  small-for-gestational-age  infants  was  30  (5.0%).
n  5  cases  (0.8%),  the  birth  weight  at  delivery  was  greater
han  4000  g,  and  the  number  of  large-for-gestational-age
nfants  was  14  (2.3%).  Three  cases  of  intrauterine  fetal
eaths  (IUFD),  three  neonatal  deaths,  one  infantile  death,
ne  CP,  one  BL,  and  one  MR  were  seen.
Table  5  shows  the  relationship  between  maternal  cardiac
esion  and  fetal  and  neonatal  poor  outcome.  There  were  no
peciﬁc  maternal  cardiac  lesions  related  to  the  occurrence
f  fetal  and  neonatal  poor  outcome.
iscussion
n  spite  of  the  recent  remarkable  progress  in  neonatal  care,
he  prognosis  of  preterm  infants  as  compared  to  that  of  term
nfants  is  still  poor;  thus,  it  must  be  the  effort  of  every  obste-
rician  to  prevent  preterm  delivery  in  both  complicated  and
on-complicated  pregnancies.
Siu  et  al.  [2]  prospectively  enrolled  562  consecutive  preg-
ant  women  with  heart  disease  and  determined  the  outcome
f  599  pregnancies  not  ending  in  miscarriage.  They  reported
hat  pulmonary  edema,  arrhythmia,  stroke,  or  cardiac  death
omplicated  13%  of  pregnancies.  Presbitero  et  al.  [5]  stud-
ed  the  outcomes  of  96  pregnancies  in  44  patients  with
yanotic  congenital  heart  disease.  They  reported  that  the
ncidence  of  maternal  cardiovascular  complications  was  high
32%),  with  one  death  from  endocarditis  2  months  after
elivery.
In  our  study,  however,  there  was  no  case  of  maternal
eath  and  this  might  be  because  of  a  selection  bias,  which
as  the  rather  strict  indication  of  pregnancy  and  delivery
n  women  with  heart  disease,  as  mentioned  in  Materials  and
ethods.  No  pregnant  women  had  baseline  NYHA  class  III
nd  IV  in  our  study,  although  Siu  et  al.  [2]  included  mothers
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ith  baseline  NYHA  class  III  at  the  pre-pregnancy  visit  in  21
regnancies  (4%).  Our  study  demonstrated  that  pregnancy
nd  delivery  were  generally  safe  in  women  with  cardiovascu-
ar  malformation  if  they  were  in  NYHA  class  I  or  II,  regardless
f  whether  they  underwent  surgery.
There  are  two  reports  concerning  the  type  of  preterm
elivery  (spontaneous  or  indicated)  in  pregnant  women
ith  cardiac  disease  [2,3]; for  example,  preterm  delivery
ccurred  in  105/599  (17.5%)  [2]  and  46/302  (15.2%)  cases
3].  The  ratio  of  spontaneous  to  indicated  preterm  deliv-
ry  has  been  reported  to  be  1.4  (62/43  cases)  [2]  and  2.1
31/15  cases)  [2,3], which  increased  because  of  spontaneous
reterm  delivery.  In  the  present  study,  preterm  delivery
ccurred  in  77  cases  (12.9%).  The  ratio  of  spontaneous  to
ndicated  preterm  delivery  was  therefore  approximately  0.5
26/51  cases).  It  is  speculated  that  the  low  incidence  of
pontaneous  preterm  delivery  in  this  study  may  have  inﬂu-
nced  this  ratio.  In  fact,  the  incidence  of  preterm  birth  in
apan  was  5.4%  in  2000  [26], less  than  half  of  the  corre-
ponding  rate  in  the  USA  (11%)  [14].
Lewis  et  al.  [27]  examined  the  prognosis  of  neonates
elivered  from  34  to  37  weeks  of  gestation.  They  reported
hat  the  morbidity  of  respiratory  distress  syndrome  in
eonates  delivered  after  34  weeks’  gestation  was  14.9%,
hile  the  morbidity  rate  from  this  condition  in  those  deliv-
red  after  35  and  36  weeks  of  gestation  has  been  reported
o  be  0%  [28]. No  effect  of  antenatal  glucocorticosteroid
herapy  has  been  shown  when  the  pregnancy  exceeds  more
han  34  weeks  of  gestation  [16]. In  addition,  in  the  man-
gement  plan  of  preterm  PROM,  immediate  delivery  is
hosen  for  women  after  34  weeks  of  gestation  [29]. From
hese  observations,  35  weeks  of  gestation  is  an  appropriate
ime  to  consider  when  making  decisions  about  interven-
ions.
In  this  case—control  study,  we  studied  the  factors  associ-
ted  with  preterm  delivery  at  less  than  35  weeks  of  gestation
n  women  with  cardiac  disease.  The  results  of  our  analysis
evealed  that  cardiac  dysfunction,  NYHA  class  II,  cardiomy-
pathy,  and  PIH  were  signiﬁcant  factors  inﬂuencing  the  risk
f  preterm  delivery.
Siu  et  al.  [1]  also  examined  the  outcomes  of  252  com-
leted  pregnancies  in  221  women  with  heart  disease  and
bserved  an  association  between  antepartum  maternal
ardiac  events  and  preterm  labor.  They  reported  that  pre-
ature  onset  of  labor  was  associated  with  an  antepartum
aternal  cardiac  event,  and  that  the  rates  of  premature
abor  in  mothers  with  and  without  antepartum  cardiac
vents  were  23%  and  9%  (p  =  0.01).  In  our  study,  the  rate  of
reterm  delivery  in  mothers  with  cardiac  events  at  less  than
7  weeks  gestation  was  12.9%,  lower  than  in  their  previous
eport.  One  reason  for  this  difference  could  be  differences
n  the  study  group.  Their  study  group  included  NYHA  I—III
ases,  but  ours  included  only  NYHA  I  and  II.
Siu  et  al.  [2]  reported  that  worsening  of  the  NYHA  class
o  III  and  IV  occurred  in  26  of  the  579  pregnancies  in  which
he  baseline  NYHA  class  was  I  or  II.  Moreover,  Kaemmerer
t  al.  [30]  examined  the  outcomes  of  122  pregnancies  in  106
atients  with  congenital  heart  disease.  Before  pregnancy,
8  patients  (73.6%)  were  in  NYHA  class  I,  19  (17.9%)  in  NYHA
lass  II,  and  none  in  NYHA  class  III  or  IV.  They  reported  that
orsening  during  pregnancy  occurred  in  27  patients  (25.5%),
ainly  during  the  second  and  third  trimesters.  In  our  cases,
m
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owever,  only  1  patient  with  surgically  corrected  TOF  fell
nto  NYHA  class  from  II  to  III  during  the  second  trimester.  We
hould  not  encourage  pregnancy  in  women  with  NYHA  III  or
V  in  our  hospital  and  this  lower  incidence  might  be  because
f  the  strict  indication  of  pregnancy  and  delivery  in  women
ith  cardiac  disease.  In  addition,  no  reports  mentioned  a
omparison  of  the  rate  of  preterm  delivery  between  NYHA
lass  I  and  II  [2,30]. In  the  present  study,  we  found  that  the
isk  of  preterm  delivery  at  less  than  35  weeks  of  gestation  in
YHA  class  II  increased  almost  four  times  compared  to  NYHA
lass  I.
Avila  et  al.  [31]  reported  the  clinical  evaluation  of  23
omen  with  hypertrophic  cardiomyopathy  and  all  patients
ere  in  NYHA  class  I/II  with  sinus  rhythm.  The  mean  ges-
ational  age  at  delivery  was  37.1  ±  2.8  weeks.  Seven  (26%)
abies  were  premature  infants  and  the  reason  for  preterm
elivery  was  not  shown.  The  considerable  heart  failure
ate  (30.3%)  illustrated  the  poor  tolerance  of  hypertrophic
ardiomyopathy  patients  to  pregnancy-related  circulatory
verload.  In  our  cases,  the  rate  of  preterm  delivery  in
omen  with  hypertrophic  cardiomyopathy  was  61.1%,  which
s  higher  than  in  that  report  [31].
Siu et  al.  [2]  reported  that  PIH  [deﬁned  as  an  increase  of
ystolic  (≥30  mmHg)  and  diastolic  (≥15  mmHg)  blood  pres-
ure]  complicated  24  pregnancies  (4%)  and  progressed  to
reeclampsia  in  50%  of  cases.  Khairy  et  al.  [4]  reported
0  pregnancies  in  53  women  with  congenital  heart  disease.
dverse  maternal  outcomes  were  preterm  delivery  (20.8%),
UFD  (2.8%),  preeclampsia  (deﬁned  as  sustained  systolic  or
iastolic  blood  pressure  >140  or  >90  mmHg,  respectively)
2.8%),  and  postpartum  hemorrhage  (7.8%)  [4].  The  rate  of
IH  in  our  study  was  6.5%,  which  is  higher  than  in  these
eports  [2,4]. The  reason  for  this  difference  may  have  been
 difference  in  the  deﬁnition  of  PIH.
A  multidisciplinary  approach  that  includes  the  avail-
bility  of  high-risk  obstetric  care,  specialized  cardiology
ssessment  and  follow-up,  and  genetic  counseling  is  rec-
mmended  for  women  with  cardiac  disease  contemplating
regnancy.  In  particular,  in  the  management  of  women  with
ardiac  disease,  it  is  important  for  perinatal  obstetricians  to
xchange  information  and  to  collaborate  with  other  special-
sts  [13]. Information  about  the  mother  and  the  fetus  should
herefore  be  registered  in  the  early  stage  of  pregnancy,
tored  on  computer  and,  speciﬁcally,  should  be  shared.
hen  a  pregnancy  registration  system  among  obstetricians
nd  other  specialists  is  developed,  and  a newborn  baby
atabase,  integrated  between  obstetricians  and  newborn  or
nfant  follow-up  specialists,  is  set  up  as  a  registration  sys-
em,  information  sharing  will  become  much  more  effective.
uch  a  registration  is  now  under  development  in  Japan  as
ell  as  in  Europe  [32].
tudy limitations
everal  limitations  should  be  considered  when  interpreting
he  results  of  this  study.  Firstly,  data  were  retrospectively
ollected  as  compared  with  a  prospective  study  [2,3], and
ore  prospective  studies  are  needed  to  conﬁrm  the  results.
econdly,  the  absence  of  randomization  in  subject  selection
ould  have  resulted  in  some  bias.
Risk
 factors
 associated
 w
ith
 preterm
 delivery
 in
 w
om
en
 w
ith
 cardiac
 disease
 
297
Table  4  Perinatal  outcomes  and  neonatal  morbidity  in  pregnant  women  with  cardiac  disease.
Group  Total  (n  =  599)  Congenital  anomalies  in  offspring  and  neonatal  morbidity  (n)
Mean  gestational  week  at  delivery  38.2  ±  2.4
Mean birth  weight  (g)  2824.7  ±  546.4
Apgar score:  <7
1 min  38
5 min  3
Short term  neonatal  morbidity
IUGR  30
IVH 1
RDS 11
Prognosis
Live births  592
Intrauterine  fetal  death  3  Down  syndrome  (1),  congenital  cystic  adenomatoid  malformation  (1),  unknown  (1)
Early neonatal  death  3  Sepsis  (1),  Down  syndrome  and  tricuspid  atresia  (1),  unknown  (1)
Infantile death  1  Ventricular  septal  defect  (1)
Long term  morbidity
Cerebral  palsy  1  Dysgenesis  of  corpus  callsum  and  short  of  stature  (1)
Borderline 1
Mental  retardation  1  Amblyopia  and  short  stature  (1)
IUGR, intrauterine fetal growth arrest; RDS, respiratory distress syndrome; IVH, intraventricular hemorrhage.
Table  5  Relationship  between  maternal  cardiac  lesion  and  fetal  and  neonatal  poor  outcomes.
Fetal  and  neonatal  poor
prognosis
Maternal  cardiac  lesion  Gestational
week  at
delivery
Reason  for  delivery  Birth
weight  (g)
Apgar  score
(1/5  min.)
IUFD Complete  atrioventricular  block  24  470
Premature ventricular  contraction  33  860
Repaired VSD  32  1830
Neonatal death Repaired  ASD  23  Active  labor  525  1  3
Marfan syndrome 31 Cardiac  dysfunction 1764 5 8
WPW syndrome 36 NRFS 2236  1  3
Infantile death  Repaired  ASD,  pulmonary  regurgitation  36  Cardiac  dysfunction  2825  6  9
Poor neonatal  outcome
Cerebral  palsy  Mitral  stenosis  32  Cardiac  dysfunction  2093  2  8
Borderline (IQ  84)  Dilated  cardiomyopathy  31  Growth  arrest  900  3  7
Mental retardation  Atrioventricular  block  (Mobitz)  27  Growth  arrest  553  5  8
ASD, atrial septal defect; VSD, ventricular septal defect; NRFS, non-reassuring fetal status; WPW, Wolff—Parkinson—White.
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